← Browse by Condition
Medical Condition
stage iv pancreatic cancer ajcc v8
Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 2, Phase 2, EARLY_Phase 1
NCT07214298 Phase 1, Phase 2
Recruiting
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Enrollment
35 pts
Location
United States
Sponsor
Roswell Park Cancer Institute
NCT04115163 Phase 2
Recruiting
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
Enrollment
67 pts
Location
United States
Sponsor
Anne Noonan
NCT04887805 Phase 2
Recruiting
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer
Enrollment
28 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT04005690 EARLY_Phase 1
Recruiting
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
Enrollment
90 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT05053971 Phase 1, Phase 2
Recruiting
Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
Enrollment
49 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04550494 Phase 2
Recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT07226856 Phase 2
Recruiting
BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
Enrollment
43 pts
Location
United States
Sponsor
Mayo Clinic
NCT06454383 Phase 1
Recruiting
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Enrollment
19 pts
Location
United States
Sponsor
City of Hope Medical Center